[1] Chaudhry R, Ghosh A, Chandolia A. Pathogenesis of MP: An update. Indian J Med Microbiol. 2016. 34(1): 7-16.
[2] Yamazaki T, Kenri T. Epidemiology of MP Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front Microbiol. 2016. 7: 693-707.
[3] Cao B, Zhao CJ, Yin YD, Zhao F, Song SF. High prevalence of macrolide resistance in MP isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010. 51(2): 189-194.
[4] Eibach D, Casalegno JS, Escuret V, G Billaud,F Morfin. Increased detection of MP infection in children, Lyon, France, 2010 to 2011. Euro Surveill. 2012. 17(8):2-4.
[5] Brown RJ, Macfarlane-Smith L, Phillips S, Chalker VJ. Detection of macrolide resistant MP in England, September 2014 to September 2015. Euro Surveill. 2015. 20(48): 30078.
[6] Bajantri B, Venkatram S, Diaz-Fuentes G. MP: A Potentially Severe Infection. J Clin Med Res. 2018. 10(7): 535-544.
[7] Yan C, Sun H, Zhao H. Latest Surveillance Data on MP Infections in Children, Suggesting a New Epidemic Occurring in Beijing. J Clin Microbiol. 2016. 54(5): 1400-1401.
[8] Zhao H, Li S, Cao L, Y Yi,G Xue,Y Feng,C Yan. Surveillance of MP infection among children in Beijing from 2007 to 2012. Chin Med J (Engl). 2014. 127(7): 1244-1248.
[9] Gao J, Xu L, Xu B, Xie Z, Shen K. Human adenovirus Coinfection aggravates the severity of MP pneumonia in children. BMC Infect Dis. 2020. 20(1): 420-424.
[10] Respiratory Branch of Chinese Pediatric Society of Editorial Board of Chinese Journal of Applied Clinical Pediatrics (2015) Expert consensus on diagnosis and treatment of MP pneumonia in children. Chinese Journal of Applied Clinical Pediatrics 30,1304–1308.
[11] Meyer Sauteur P M , Unger W W J , Van Rossum A M C , C Berger. The Art and Science of Diagnosing Mycoplasma pneumoniae Infection[J]. Pediatr Infect Dis J. 2018 Nov;37(11):1192-1195.
[12] Clinical Laboratory Science Group of Pediatrics Branch of Chinese Medical Association. Consensus of Chinese experts on laboratory diagnosis of MP respiratory tract infection in children.Chin J Lab Med. 2019,42 (7):507-513.
[13] Salih W, Schembri S, Chalmers JD. Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data. Eur Respir J. 2014. 43(3): 842-851.
[14] Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Association CM, Editorial Board, Chinese Journal of Pediatrics. [Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)]. Zhonghua Er Ke Za Zhi. 2013. 51(10): 745-752.
[15] Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. MP from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017. 30(3): 747-809.
[16] Brown RJ, Nguipdop-Djomo P, Zhao H, Stanford E, Spiller OB, Chalker VJ. MP Epidemiology in England and Wales: A National Perspective. Front Microbiol. 2016. 7: 157.
[17] Xue G, Li M, Wang N, J Zhao,W Bei,Z Ren,et al. Comparison of the molecular characteristics of MP from children across different regions of China. PLoS One. 2018. 13(8): e0198557:1-10.
[18] Arnold FW, Summersgill JT, Lajoie AS, P Peyrani,Julio A Ramirez. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007. 175(10): 1086-1093.
[19] Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant MP pneumonia in Korean children. Korean J Pediatr. 2017. 60(5): 151-157.
[20] Zhang Xx. Epidemiological analysis of MP infection in children with respiratory tract diseases in Suzhou area from 2005 to 2014. China Medical Abstracts (Internal Medicine). 2016. v.33(1): 15-16.
[21]Onozuka D, Hashizume M, Hagihara A. IMPact of weather factors on MP pneumonia. Thorax. 2009. 64(6): 507-511.
[22] Eun BW, Kim NH, Choi EH, Lee HJ. MP in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect. 2008. 56(5): 326-331.
[23] Defilippi A, Silvestri M, Tacchella A, R Giacchino,GA Rossi. Epidemiology and clinical features of MP infection in children. Respir Med. 2008. 102(12): 1762-1768.
[24] Bosnak M, Dikici B, Bosnak V, O Dogru,I Ozkan,A Ceylan,et al. Prevalence of MP in children in Diyarbakir, the south-east of Turkey. Pediatr Int. 2002. 44(5): 510-512.
[25] Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with MP. J Infect Dis. 1979. 139(6): 681-687.
[26] Qu J, Yang C, Bao F, Chen S, Gu L, Cao B. Epidemiological characterization of respiratory tract infections caused by MP during epidemic and post-epidemic periods in North China, from 2011 to 2016. BMC Infect Dis. 2018. 18(1): 335-338.
[27] Gao LW, Yin J, Hu YH, XY Liu,KL Shen. The epidemiology of pediatric MP pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019. 147: e192:1-5.
[28] Qian Q, Ji W. Epidemiological features of children hospitalized with mycoplasma pneumoniae infection from the year of 2006 to 2014.Chongqing Med 2016. 45(29): 4113-4116.
[29] Kogoj R, Mrvic T, Praprotnik M, Kese D. Prevalence, genotyping and macrolide resistance of MP among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill. 2015. 20(37).
[30] He J, Liu M, Ye Z, Tan TP,Hui X,Xiao X. Insights into the pathogenesis of MP (Review). Mol Med Rep. 2016.14(5): 4030-4036.
[31]Dimitri, Poddighe. Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis[J]. Curr Opin Rheumatol.2018 Jul;30(4):380-387.
[32] Miyashita N, Obase Y, Ouchi K, K Kawasaki,Y Kawai,Y Kobashi,et al. Clinical features of severe MP pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007. 56(Pt 12): 1625-1629.
[33] Wang CY, Wang SB, Liu GH, Song CM, Chen Q. Analysis of correlations between clinical characteristics and pediatric critical illness score in children with severe Mycoplasma pneumoniae pneumonia. Chin J Evid Based Pediatr.2016.11(4): 280-284.
[34] Jing XY, Lu M. Risk factors and clinical significance of severe mycoplasma pneumoniae pneumonia. Int J Pediatr. 2016. 43(7): 519-522.
[35] Yan C, Xue G, Zhao H, Y Feng,S Li,J Cui,et al. Molecular and clinical characteristics of severe MP pneumonia in children. Pediatr Pulmonol. 2019. 54(7): 1012-1021.
[36] Robnik B, Kese D, Rojko T, A Horvat-Ledinek,Pranikar, Ale,B Beovic. Unilateral brachial plexopathy, a rare complication of Mycoplasma pneumoniae infection[J]. J Infect Chemother. 2018 Apr; 24(4):309-311.
[37] American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Obstet Gynecol. 2016;127(2):e75-80.